EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial

David C Gaston iD, Romney M Humphries iD, Ariel A Lewis iD, Cheryl L Gatto iD, Li Wang, George E Nelson, Joanna L Stollings iD, Benjamin J Ereshefsky, Matthew A Christensen, Mary Lynn Dear, Ritu Banerjee iD, Matthew Rodgers und 7 weitere

Clinical Infectious Diseases · 25.02.2026 · 82 (2) · e227-e235

DOI: 10.1093/cid/ciaf677 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 15.01.2026. Verfasst von David C Gaston und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, T2 Biosystems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

For hospitalized adults receiving empiric antibiotic therapy, antibiotic de-escalation prevents unnecessary exposure and adverse effects. Whether use of direct-from-blood bacterial testing facilitates earlier antibiotic de-escalation and improves clinical outcomes has never been evaluated in a randomized trial.

Methods

Between December 2023 and December 2024, this pragmatic randomized trial compared direct-from-blood bacterial testing with blood cultures (intervention group) to blood cultures alone (usual care group) in adults with suspected infection receiving empiric intravenous vancomycin in the emergency department of an academic medical center. The primary and secondary outcomes were time from randomization to last dose of intravenous vancomycin and systemic antipseudomonal beta-lactam antibiotics, respectively.

Results

Among 500 patients enrolled, the time from randomization to results of bacterial testing from blood (direct-from-blood test, gram stain, or negative culture) was a median of 5.2 days shorter (95% CI, 5.1–5.2) in the direct-from-blood test group (median 0.4 days; IQR, 0.3–0.5) than the usual care group (median, 5.5 days; IQR, 5.2–5.6). The time between randomization and the last dose of intravenous vancomycin did not differ between the direct-from-blood test group (median, 12.5 hours; IQR, 0.79–57.8) and the usual care group (median, 19.0 hours; IQR 0.9–64.8) (HR, 1.08; 95% CI, .90–1.28; P = .42), nor did the time to last dose of systemic antipseudomonal beta-lactam antibiotics (HR, 1.04; 95% CI .87–1.24). Clinical outcomes were also similar.

Conclusions

Among adults with suspected infection receiving empiric intravenous vancomycin in the emergency department, use of direct-from-blood bacterial testing did not shorten the duration of intravenous vancomycin or antipseudomonal beta-lactam antibiotics.

Schlagwörter

Stichwörter der Autor:innen

antibiotic stewardshiplearning healthcare systemmolecular diagnosticspragmatic clinical trial

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: David C Gaston, Romney M Humphries, Ariel A Lewis, Cheryl L Gatto, Joanna L Stollings, Ritu Banerjee, Wesley H Self, Matthew W Semler, Edward T Qian

Förderung

  • NIGMS NIH HHS
  • T2 Biosystems

Zitieren

APA

Gaston, D. C., Humphries, R. M., Lewis, A. A., Gatto, C. L., Wang, L., Nelson, G. E., Stollings, J. L., Ereshefsky, B. J., Christensen, M. A., Dear, M. L., Banerjee, R., Rodgers, M., Benton, A., Glover, S., Miller, K. F., Self, W. H., Semler, M. W., Qian, E. T., & Vanderbilt Center for Learning Healthcare (2026). Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial. Clinical Infectious Diseases, 82(2), e227-e235. https://doi.org/10.1093/cid/ciaf677

Vancouver

Gaston DC, Humphries RM, Lewis AA, Gatto CL, Wang L, Nelson GE, et al. Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial. Clinical Infectious Diseases. 2026;82(2):e227-e235. doi:10.1093/cid/ciaf677

BibTeX
@article{Gaston2026,
  author = {Gaston, David C and Humphries, Romney M and Lewis, Ariel A and Gatto, Cheryl L and Wang, Li and Nelson, George E and Stollings, Joanna L and Ereshefsky, Benjamin J and Christensen, Matthew A and Dear, Mary Lynn and Banerjee, Ritu and Rodgers, Matthew and Benton, Alison and Glover, Sharon and Miller, Karen F and Self, Wesley H and Semler, Matthew W and Qian, Edward T and Vanderbilt Center for Learning Healthcare, Vanderbilt Center for Learning Healthcare},
  title = {Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {82},
  number = {2},
  pages = {e227--e235},
  doi = {10.1093/cid/ciaf677}
}
Kostenlos starten →